Anti-hypertensive 'herbal' compound contaminated with prescription drugs
hypertension, after finding that several of its ingredients are
prescription drugs, with potentially serious health risks to
consumers.
New York retailer Tai Chien is recalling a product marketed to help hypertension, after finding that several of its ingredients are prescription drugs, with potentially serious health risks to consumers.
Ancom Anti-Hypertensive Compound Tablets, an unapproved new drug labeled to contain reserpine, diazepam, promethiazine, and hydrochlorothiazide, has previously been involved in a recall in January.
According to the Tai Chen statement, the sale of a product with this combination of ingredients poses possible serious health risks including sedation, depression, and potentially life-threatening abnormalities of the blood.
The recall, being conducted with the FDA, includes all lot codes of the 100-tablet product remaining on the market.
Ancom tablets are labeled 'Anti-hypertensive Compound', and display the manufacturer's name as Shanghai Pharmaceutical Industry, Shanghai, China.
At least one illness has been reported to date. Consumers who purchased Ancom Anti-Hypertensive Compound Tablets are being urged to immediately discontinue use of the product and return it to the place of purchase for a full refund.
